BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/4/2015 12:50:00 PM | Browse: 1217 | Download: 2259
Publication Name World Journal of Respirology
Manuscript ID 14227
Country Portugal
ISSN 2218-6255 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title Myasthenia gravis as a form of clinical presentation of thymic carcinoma
Manuscript Source Invited Manuscript
All Author List Joana Espiga de Macedo, Sílvia Lopes, Helena Gouveia, Sofia Oliveira, João Cunha, Ana Luísa Faria, Sónia Rego, Albino Oliveira, Luís Krug and Emílio Macias Bravo
Funding Agency and Grant Number
Corresponding Author Joana Espiga de Macedo, MD, Department of Medical Oncology of Centro Hospitalar de Entre o Douro e Vouga, Rua Dr. Cândido de Pinho, 4520-211 Santa Maria Da Feira, Portugal. joanamacedo@hotmail.com
Key Words Myasthenia gravis; Thymic carcinoma; Multidisciplinary approach; Clinical-molecular signature; Prognosis
Core Tip We report a rare form of clinical presentation of a thymic carcinoma in which the diagnosis of myasthenia gravis was the cornerstone of the dia?gnosis of cancer. Surgery is considered the salvage treatment when possible. Radiotherapy is a second choice of salvage treatment, when possible depending on its localization and relation to nearby structures such as vascular structures. The prognosis is very reserved, when neither surgery nor radiotherapy can be accomplished. Having an unfavorable molecular signature, less than 10% of thymic carcinomas have c-kit mutations, and clinical outcome of these patients is detrimental.
Publish Date 2015-08-04 12:43
Citation de Macedo JE, Lopes S, Gouveia H, Oliveira S, Cunha J, Faria AL, Rego S, Oliveira A, Krug L, Bravo EM. Myasthenia gravis as a form of clinical presentation of thymic carcinoma. World J Respirol 2015; 5(2): 176-179
URL http://www.wjgnet.com/2218-6255/full/v5/i2/176.htm
DOI http://dx.doi.org/10.5320/wjr.v5.i2.176
Full Article (PDF) WJR-5-176.pdf
Full Article (Word) WJR-5-176.doc